Objective. To assess intercentre variability in the ACR core set measures, DAS28 based on three variables (DAS28v3) and Routine Assessment of Patient Index Data 3 in a multinational study.
Introduction
There is currently no gold standard measure or test for RA activity assessment. Hence, RA activity assessment is derived from multiple measures including one or more of physician assessed measures, patient reported outcomes (PROs) and laboratory markers of inflammation [1, 2] . Ideally, the variability in RA activity assessment measures should only be influenced by RA inflammation. However, poor reliability has been reported both for physician assessed measures and PROs [35] .
Clinical trials and epidemiological RA studies often recruit patients from multiple centres. No study has examined the relative differences in variance of different RA activity measures among patients assessed by different physicians or at different centres. Understanding such differences could help identify RA activity measures that are more comparable across centres, and measures that may need standardization. Our objective was to study the proportion of variance in scores of (i) the ACR core set measures [1] , (ii) DAS28 (representative physician and laboratory measure derived composite index) [6] , and (iii) Routine Assessment of Patient Index Data 3 (RAPID3, representative PRO-derived composite index) explained by intercentre (or between-centre) differences (as surrogate of different physician) in a multinational study [7] .
Methods

Study population
The Quantitative Standard Monitoring of Patients with RA (QUEST-RA) study recruited RA patients receiving usual care from rheumatologists in three or more rheumatology clinics in several countries [8] . One hundred non-selected consecutive RA patients were recruited from each participating clinic and assessed using a standard protocol. A centre represented each study site for our analyses. Information was obtained about the seven ACR core set measures [tender joint count based on 28-joint assessment (TJC28), swollen joint count based on 28-joint assessment (SJC28), physician's global assessment of RA activity (MDGL), ESR, pain, patient's global assessment of RA activity (PTGL), physical function by the HAQ]. DAS28 based on three variables (DAS28v3) was used as it does not include any PRO and was calculated by the formula [0.56 Âˇ(TJC28) + 0.28 Âˇ(SJC28) + 0.70 Â ln(ESR)] Â 1.08 + 0.16 [6] . RAPID3 was calculated by the formula HAQ Â 3.3 + Pain + PTGL [7] . The QUEST-RA study was carried out in compliance with the Declaration of Helsinki. Ethics committees or internal review boards of participating institutes approved the study. This analysis of de-identified data from the QUEST-RA study did not require approval.
Statistical analysis
Analysis of variance and mixed-effect analysis of covariance models were constructed to assess intercentre variance in the study measures. A base model included only the patient recruiting centre (clinic) as a variable. The ACR core model included variables shown in Table 1 . In general, each ACR core set variable was modelled as a function of the remaining core set measures except the global score(s) as conceptually global scores represent overall impression by the patient or the physician about RA disease activity [9, 10] . DAS28v3 and RAPID3 models excluded ACR core set measures that are components of these indices. The demographic/medical model had demographic variables, RA characteristics and comorbidities that may influence patient experience or physician assessment of RA. Psychological distress was assessed by psychological HAQ and comorbidity burden by an index derived from 10 comorbidities [9, 10] . Finally, a full model including variables in both the ACR and demographic/medical models was constructed. A variable representing the patient recruiting centre was included in all models. Analysis of variance tables were used to decompose the total variance or sums of squares (SS total ) to those attributable to the predictors (SS predict ), the patient recruiting centre (SS centre ) and residual (SS residual ). We report the percentage of the total variance of each study measure that is explained by the predictors, the centre and residual (unexplained). An analysis of covariance approach that accounts for unequal variances and correlated data showed similar results. Multiple imputations of missing data were performed as detailed previously [9, 10] .
Results
Seven thousand five hundred and sixty-eight patients from 84 centres located in 30 countries were assessed; 545 (7.2%) patients were excluded either because information on two or more ACR core set measures or five or more study variables were missing. Seven thousand and twentythree patients (4004 with complete and 3019 with data imputed for 51 variable) with a mean age (S.D.) of 55 (14) years and disease duration of 10.8 (9.5) years were included in the analysis; 79.8% were women and 72.1% were white. The mean (S.D.) DAS28v3 and RAPID 3 were 4.3 (1.7) and 11.4 (7), respectively. Supplementary Table S1, available at Rheumatology Online, provides the details of the demographics and clinical characteristics of the study patients. Table 2 shows the SS total (total variance) and percentage of variance explained by the predictors in the models, recruiting centre and residual for the ACR core set measures, RAPID3 and DAS28v3. Compared with the ACR core set model, the demographics/medical model explained variance in pain (43.75% vs 43.71%) and HAQ scores (40.62% vs 45.25%) similarly, but much less for the TJC28 (20.10% vs 42.93%), SJC28 (10.73% vs 35.70%) and ESR (8.41% vs 13.93%). Variance in both the global scores (PTGL and MDGL) was better explained by the ACR core set model than the demographic/medical model. RAPID3 variance was much better explained by the medical/demographic model compared with DAS28v3. A large proportion of variance (ranging from 35.74% for MDGL to 75.95% for ESR in the full model) in our study measures remained unexplained despite the inclusion of several sociodemographic, RA and other medical characteristic related variables in the models.
As expected, the variance explained by between centre differences for each study measure was most for the base model that had centre as the only variable and least for the full model. In each of the four models, the variances in PROs were less likely to be explained by between centre differences (ranging from 1.53% for PTGL to 3.71% for HAQ in the full model) compared with physician assessed measures and ESR (ranging from 5.92% for MDGL to 9.25% for TJC28 in the full model). Similarly, much larger proportion of variance in DAS28v3 (11.75% in the full model) was explained by the recruiting centre compared with RAPID3 (2.60% in the full model). The proportion of the total known variance (as measured by the sum of the SS predict and SS clinic ) accounted for by differences due to centres was considerably lower for patient reported measures [pain (3.8%), PTGL (2.5%), HAQ (6.43%) for the full model] compared with physician derived and laboratory measures [SJC28 (17.50%), TJC28 (16.87%) and ESR (32.7%) for the full model]. Similar relative differences in the intercentre variance were found for RAPID3 (4.17%) and DAS28v3 (23.4%) as were noted in the full model.
Discussion
We examined intercentre variability in the ACR core set measures, RAPID3 and DAS28v3 in the QUEST-RA study through analysis of data from 84 centres across 30 countries. The wide geographical area covered is a unique feature of this study. Inherent differences in social, economic and healthcare systems unavoidably translate into large differences in RA activity measures [8] . Consequently, multiple models were constructed to adjust for the differences in RA activity measures, socio-demographics, RA characteristics and comorbidities to study intercentre variability. Our results show that relative intercentre differences were lower for PROs than physician assessed measures and ESR. This translated into much larger intercentre variance in DAS28v3 compared with RAPID3.
Our study is relevant for the planning and conduct of multicentre RA clinical trials and epidemiological studies. Multicentre studies and consortia have the advantage of allowing for rapid recruitment of patients from a wide range of settings. An unavoidable consequence of multicentre data collection is data clustering: individuals within centres are more similar than those from different centres [11, 12] . Data clustering may result from non-random differences in measurements taken by different physicians recruiting in different centres, differences in laboratory equipment and test conducting, and differences in the patient population such as socio-cultural characteristics [11, 12] .
Intraclass or intracluster correlation (ICC), defined as the proportion of total variance in an outcome attributed to differences between centres or clusters, has been used to assess intercentre variance [12, 13] . The intercentre variance in our study outcome measures seems relatively small, ranging from 1.53 to 11.75% in the full model. For a comparative perspective, median (interquartile range) ICC for 1039 outcomes from 31 primary care studies was 0.01 (00.032) corresponding to median 1% (03.2%) intercentre variance [14] . Among 48 ICCs in 10 multicentre surgery trials, 15% were between 0.05 and 0.10 and 29% were >0.10 [13] .
Failure to account for centre effects, particularly with 55% intercentre measure variance, in multicentre trials can inflate variance, bias estimates of treatment effect and reduce the power of a study by lowering the effective sample size [11, 12] . This was exemplified by an RA clinical trial of epitope-specific immunotherapy that enrolled 160 patients from 11 centres in the USA and Mexico that did not meet an a priori primary end point. However, after adjusting for sizable differences in clinical effect between centres, a significant clinical effect was found [15] . Inclusion of cluster effect, particularly when relatively strong (ICC 5 5%), also results in better performance of prediction models derived from multicentre data [16] . Statistical approaches that allow for assessment of clustering effect have been proposed as a quality control measure for the centre clustering effect during the conduct of multicentre studies [17] . The clustering effect was stronger for objective outcomes (TJC, SJC, MDGL and ESR) compared with PROs (pain, HAQ and PTGL). The relatively small intercentre variance in PROs is surprising given patient recruitment from very diverse socio-economic, cultural and educational backgrounds. This suggests that disease experience of RA is quite similar across a wide range of patient populations. Swollen and tender joints count assessment by physicians is the most conventional way of detecting clinical synovitis, and is predictive of radiographic progression [18] . These objective measures make a disproportionately larger contribution to assess RA disease activity and treatment response in clinical trials and most observational studies. Our data highlight the importance of measures to standardize joint count methodology and laboratory assays. Standardized joint examination training has been shown to significantly reduce interassessor variability [19] . However, a recent systematic review found inconclusive evidence for training to improve SJC reliability, and further evaluation of patient-reported joint counts as an outcome measure was proposed [5] . Our results also underscore the importance of developing new RA activity assessment biomarkers that are more amenable to standardization.
Our study has certain limitations. Our results may potentially be misinterpreted as showing the superiority of PROs compared with more objective outcomes for RA activity assessment. We only assessed an aspect (intercentre variance) of these measures. In this narrow sense, PROs appear to be more comparable across multiple centres compared with the joint counts and ESR. Specific information about provider assessing patients in each centre was lacking, and intercentre variability may not strictly be identical to interphysician variability. No formal attempt was made to train study investigators for standardising joint examination, although the majority of investigators had participated in RA clinical research studies. A large proportion of variance in study variables remained unexplained despite the inclusion of most conventional RA disease activity measures, socio-demographics, and comorbidities (relatively more for objective measures than PROs). This likely reflects widely dispersed recruiting centres that would invariably introduce unmeasured patient and physician related social, cultural and economic influences. Compared with a two-centre RA study from Vienna, Austria where ACR Spina ventosa-a rare cause of sausage digit A 21-year-old female presented to us with a 2-month history of painful swelling involving her right index finger with low-grade fever. Examination demonstrated a visibly enlarged index finger with a firm, fusiform swelling that involved the proximal and middle phalanges, with overlying erythema (Fig. 1A) . Movements were painful. History of local trauma, cough, bowel or menstrual disturbance and immunosuppression could not be elicited. Serum HIV and VDRL were negative. Serum uric acid concentration and Xrays of chest and spine were normal. X-Ray of the digit showed cortical erosion in the distal part of proximal phalanx, minimal periosteal reaction and soft tissue swelling (Fig. 1B) . Biopsy revealed granulomatous inflammation in the dermis and subcutaneous fat, with necrosis and Langhan's giant cells. Staining and culture for bacteria, fungi and mycobacteria were negative. Mantoux test was strongly positive (34 mm). A diagnosis of tubercular dactylitis/spina ventosa was made. The patient was started on anti-tubercular treatment and had significant improvement in the swelling at a follow-up of 2 months (Fig. 1C) .
Dactylitis or sausage digit is an inflammatory fusiform digital swelling. Differentials include infections (pyogenic osteomyelitis, tuberculosis, phaeohyphomycosis), PsA, sarcoidosis, reactive arthritis, gout and bone tumours. Spina ventosa is tubercular osteomyelitis of the phalanges that can spread to overlying soft tissues causing sausage digit. Although rare, it is important to consider tuberculosis as cause of sausage digit in an endemic area because of the excellent response to anti-tubercular treatment [1, 2] .
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